BRPI0906573A2 - Método para determinação da sensibilidade para agentes anticâncer - Google Patents
Método para determinação da sensibilidade para agentes anticâncerInfo
- Publication number
- BRPI0906573A2 BRPI0906573A2 BRPI0906573-3A BRPI0906573A BRPI0906573A2 BR PI0906573 A2 BRPI0906573 A2 BR PI0906573A2 BR PI0906573 A BRPI0906573 A BR PI0906573A BR PI0906573 A2 BRPI0906573 A2 BR PI0906573A2
- Authority
- BR
- Brazil
- Prior art keywords
- anticancer agents
- determining sensitivity
- sensitivity
- determining
- anticancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4727—Calcium binding proteins, e.g. calmodulin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Electrochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008021124 | 2008-01-31 | ||
| JP2008223384 | 2008-09-01 | ||
| PCT/JP2009/000374 WO2009096196A1 (ja) | 2008-01-31 | 2009-01-30 | 抗がん剤感受性の判定方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0906573A2 true BRPI0906573A2 (pt) | 2015-07-07 |
Family
ID=40912550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0906573-3A BRPI0906573A2 (pt) | 2008-01-31 | 2009-01-30 | Método para determinação da sensibilidade para agentes anticâncer |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9089540B2 (pt) |
| EP (1) | EP2241334A4 (pt) |
| JP (1) | JP5461201B2 (pt) |
| KR (1) | KR20100130587A (pt) |
| CN (2) | CN104784706A (pt) |
| AU (1) | AU2009208526A1 (pt) |
| BR (1) | BRPI0906573A2 (pt) |
| CA (1) | CA2713296A1 (pt) |
| IL (1) | IL207169A0 (pt) |
| MX (1) | MX2010008496A (pt) |
| NZ (1) | NZ586972A (pt) |
| RU (1) | RU2010136309A (pt) |
| WO (1) | WO2009096196A1 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3081941B1 (en) | 2009-10-30 | 2018-06-27 | Keio University | Method for determination of sensitivity to anti-cancer agent |
| WO2011052750A1 (ja) * | 2009-10-30 | 2011-05-05 | 学校法人慶應義塾 | 抗がん剤の感受性判定マーカー |
| EP2495568B1 (en) | 2009-10-30 | 2018-08-22 | Keio University | Method for determining sensitivity to an anticancer agent |
| WO2012110425A1 (en) * | 2011-02-14 | 2012-08-23 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for monitoring the response to treatment and for treating colorectal cancer |
| EP3139172A3 (en) * | 2011-03-24 | 2017-06-14 | Keio University | Marker for determination of sensitivity to anticancer agent |
| CN108508168B (zh) | 2012-02-23 | 2021-08-17 | 学校法人庆应义塾 | 并用抗癌剂的感受性判定标记 |
| SG11201606439VA (en) | 2014-02-07 | 2016-09-29 | Dong Wha Pharm Co Ltd | Anticancer adjuvant composition containing rip3 expression promoter as active ingredient, method for screening for anticancer adjuvant enhancing sensitivity of anticancer drug by promoting rip3 expression, and method for monitoring sensitivity of anticancer drug |
| WO2015119362A1 (ko) * | 2014-02-07 | 2015-08-13 | 아주대학교산학협력단 | Rip3 발현촉진제를 유효성분으로 포함하는 항암보조용 조성물, rip3 발현을 촉진하여 항암제 감수성을 증진시키는 항암 보조제 스크리닝 방법 및 항암제 감수성 모니터링 방법 |
| US20170248578A1 (en) * | 2014-08-26 | 2017-08-31 | Keio University | Anti-cancer agent sensitivity-determining marker |
| WO2016169755A1 (en) | 2015-04-21 | 2016-10-27 | Philips Lighting Holding B.V. | Lighting-control processor and method for operating a lighting-control processor |
| KR101834378B1 (ko) * | 2015-08-05 | 2018-03-06 | 아주대학교산학협력단 | Rip3 발현촉진제를 유효성분으로 포함하는 항암보조용 조성물, rip3 발현을 촉진하여 항암제 감수성을 증진시키는 항암 보조제 스크리닝 방법 및 항암제 감수성 모니터링 방법 |
| JP7203391B2 (ja) * | 2018-03-29 | 2023-01-13 | 慶應義塾 | イリノテカンを含む抗がん剤療法の感受性判定マーカー |
| WO2020067228A1 (ja) * | 2018-09-28 | 2020-04-02 | 学校法人慶應義塾 | 併用抗がん剤の感受性の判定マーカー |
| JP7384410B2 (ja) | 2020-08-27 | 2023-11-21 | 国立大学法人 大分大学 | 癌治療効果の有効性を予測する方法、予測装置及び予測プログラム |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040076955A1 (en) * | 2001-07-03 | 2004-04-22 | Eos Biotechnology, Inc. | Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer |
| US20070054271A1 (en) * | 2003-03-20 | 2007-03-08 | Dana-Farber Cancer Institute, Inc. | Gene expression in breast cancer |
| WO2005007846A1 (ja) * | 2003-04-25 | 2005-01-27 | Japanese Foundation For Cancer Research | 腫瘍細胞の抗癌剤に対する感受性を判定する方法 |
| CN1922332B (zh) * | 2003-12-31 | 2013-06-12 | 宾夕法尼亚州研究基金会 | 预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法 |
| GB0412620D0 (en) | 2004-06-05 | 2004-07-07 | Univ Belfast | BRCA1 markers |
| WO2007058968A2 (en) * | 2005-11-12 | 2007-05-24 | Bayer Healthcare Llc | Gene expression profiles and methods of use |
| AU2007251933B2 (en) * | 2006-05-19 | 2011-05-12 | F. Hoffman-La Roche Ag | Use of protein S100A 12 as a marker for colorectal cancer |
| CN101040843A (zh) | 2006-09-22 | 2007-09-26 | 济南康泉医药科技有限公司 | 一种含尼莫司汀及其增效剂的抗实体瘤缓释剂 |
| US20100216131A1 (en) * | 2006-12-11 | 2010-08-26 | Rajyalakshmi Luthra | Gene expression profiling of esophageal carcinomas |
| CN101011351A (zh) | 2007-02-12 | 2007-08-08 | 济南帅华医药科技有限公司 | 同载铂类化合物和增效剂的抗癌组合物 |
| EP2140020A2 (en) * | 2007-03-15 | 2010-01-06 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
-
2009
- 2009-01-30 WO PCT/JP2009/000374 patent/WO2009096196A1/ja active Application Filing
- 2009-01-30 JP JP2009551440A patent/JP5461201B2/ja not_active Expired - Fee Related
- 2009-01-30 US US12/865,726 patent/US9089540B2/en not_active Expired - Fee Related
- 2009-01-30 AU AU2009208526A patent/AU2009208526A1/en not_active Abandoned
- 2009-01-30 MX MX2010008496A patent/MX2010008496A/es not_active Application Discontinuation
- 2009-01-30 CA CA2713296A patent/CA2713296A1/en not_active Abandoned
- 2009-01-30 CN CN201510075217.3A patent/CN104784706A/zh active Pending
- 2009-01-30 RU RU2010136309/15A patent/RU2010136309A/ru not_active Application Discontinuation
- 2009-01-30 KR KR1020107016145A patent/KR20100130587A/ko not_active Application Discontinuation
- 2009-01-30 BR BRPI0906573-3A patent/BRPI0906573A2/pt not_active IP Right Cessation
- 2009-01-30 NZ NZ586972A patent/NZ586972A/en not_active IP Right Cessation
- 2009-01-30 EP EP09706388.7A patent/EP2241334A4/en not_active Withdrawn
- 2009-01-30 CN CN2009801039330A patent/CN101932338A/zh active Pending
-
2010
- 2010-07-22 IL IL207169A patent/IL207169A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2010136309A (ru) | 2012-03-10 |
| IL207169A0 (en) | 2010-12-30 |
| AU2009208526A1 (en) | 2009-08-06 |
| JPWO2009096196A1 (ja) | 2011-05-26 |
| MX2010008496A (es) | 2010-08-30 |
| US9089540B2 (en) | 2015-07-28 |
| CN101932338A (zh) | 2010-12-29 |
| WO2009096196A1 (ja) | 2009-08-06 |
| EP2241334A1 (en) | 2010-10-20 |
| EP2241334A4 (en) | 2013-06-19 |
| CN104784706A (zh) | 2015-07-22 |
| CA2713296A1 (en) | 2009-08-06 |
| US20100323034A1 (en) | 2010-12-23 |
| KR20100130587A (ko) | 2010-12-13 |
| JP5461201B2 (ja) | 2014-04-02 |
| NZ586972A (en) | 2012-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0906573A2 (pt) | Método para determinação da sensibilidade para agentes anticâncer | |
| DK2273984T3 (da) | Lipidsammensætning | |
| BRPI0921242A2 (pt) | composições para tratamento bucal para sensibilidade. | |
| DK3431076T3 (da) | Forbedret lipidformulering | |
| IT1392524B1 (it) | Metodo per misure radar interferometriche | |
| BRPI0919116A2 (pt) | método | |
| DK2308877T3 (da) | Imidazopyridin-2-on-derivater | |
| DK2300777T3 (da) | Cylinderdiametermåling | |
| BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
| BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
| FI20095868A0 (fi) | Poljinmittaus | |
| DK2313489T3 (da) | Fremstillingsmetode | |
| DE112008003988A5 (de) | Abstandsmesssystem | |
| DK2239253T3 (da) | Hidtil ukendt phenylpyrrolderivat | |
| BRPI0909160A2 (pt) | rolamentos | |
| DK2275414T3 (da) | Cyclopentylacrylamidderivat | |
| BRPI0909488A2 (pt) | brocha | |
| DK2301001T3 (da) | Parkeringspositionsindikator | |
| BR112012004102A2 (pt) | métodos de ensaio | |
| BRPI0911625A2 (pt) | Métodos | |
| ATE545635T1 (de) | Substituierte n-oxidpyrazinderivate | |
| BRPI0913234A2 (pt) | derivados de tiazolilpiperidina | |
| DE112009000730A5 (de) | Gleitlager | |
| ATE534634T1 (de) | 2-phenyl-4-cyclopropyl-pyrimidinderivate | |
| BRPI0922652A2 (pt) | Derivados de quinazolinamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2363 DE 19-04-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |